Tagcloud

ACE inhibitor, acetylcholinesterase inhibitor, aciclovir, acne, acute coronary syndrome, acute lymphoblastic leukaemia, ADHD, advanced prostate cancer, advanced renal cell carcinoma, advanced soft tissue sarcoma, adverse reaction, agomelatine, agoraphobia, alendronic acid, alfuzosin, algorithm, aliskiren, allergic rhinitis, allopurinol, alpha1-proteinase inhibitor, Alzheimer's, amantadine hydrochloride, ambrisentan, aminosalicylate, amlodipine, amoxicillin, anaemia, angina pectoris, anidulafungin, ankylosing spondylitis, anti-doping, anti-heparin, anti-human thymocyte immunoglobulin, antibacterial, antibiotic, anticoagulant, antidepressant, antineoplastic, antipsychotic, antiretroviral, antiretroviral therapy, anxiety, aromatase inhibitor, asthma, atazanavir, azacitidine, bacterial infections, BCG Vaccine, beclometasone, behaviour disorders, betamethasone, bevacizumab, bicalutamide, bipolar disorder, bisoprolol fumarate, bisphosphonates, black patients, bladder cancer, bowel cleansing, BPH, breakthrough pain, breast cancer, brinzolamide, bronchospasm, budesonide, bulimia nervosa, calcipotriol, calcium, candesartan, Candida albicans, candidiasis, carbetocin, carbidopa, cardiac insufficiency, cardiovascular disease, cefaclor, ceftriaxone, cefuroxime, cephalosporin, cetirizine, CHF, cholecalciferol, chronic constipation, chronic heart failure, Chronic Kidney Disease, chronic myeloid leukaemia, chronic myelomonocytic leukaemia, chronic pain, chronic pulmonary infection, ciprofloxacin, citalopram hydrobromide, clarithromycin, clavulanic acid, clopidogrel, clotrimazole, clozapine, colorectal cancer, contraception, COPD, coronary artery disease, Crohn’s Disease, cystic fibrosis, dabigatran etexilate, daptomycin, darunavir, dasatinib, degarelix, dementia, depression, dermatophytes, dermatophytose, desogestrel, diabetes, diclofenac, dienogest, diphteria, discontinuations, domperidone, donepezil, doxazosin, doxycycline, drospirenone, duodenal ulcer, dyslipidaemia, eczema, eletriptan, emetogenic cancer chemotherapy, enalapril, endocarditis, entacapone, epigastric bloating, epilepsy, epirubicin, epoetin, ErbB2 (HR2) receptors, erythropoiesis-stimulating agents, esomeprazole, estradiol, ethinylestradiol, etravirine, everolimus, exemestane, faecal impaction, famciclovir, fentanyl, fesoterodine, fever, filgrastim, finasteride, fluconazole, fluoxetine, flurbiprofen, fluvastatin, folate, folic acid, follicular development stimulation, follicular lymphoma, follitropin alpha, fosprepitant, fungal infections, gabapentin, gastric cancer, gastric ulcer, gastroduodenal ulcer, gemcitabine, gestodene, gliclazide, glucosamine sulphate, gonorrhoea, GORD, growth failure, H1N1, hayfever, heart failure, heart rate, Helicobacter pylori, hepatic failure, hepatitis, hepatocellular carcinoma, herpes, hip or knee replacement surgery, hip osteoarthritis, HIV, hyaluronic acid, hydrochlorothiazide, Hylan G-F 20, hypercholesterolaemia, hyperlipidaemia, hyperphosphataemia, hypertension, hyperuricaemia, hypoactive sexual desire disorder, ibritumomab, ibuprofen, IGF-1 deficiency, IMB, immunosuppression, indacaterol, indapamide, infections, inflammation, influenza, insomnia, interferon beta-1a, iobetasol, IOP, ipatropium bromide, irinotecan, Irish Sports Council, ischaemic stroke, isotretinoin, ivabradine, Kaposi's sarcoma, kidney cancer, kidney disease, knee osteoarthritis, lacosamide, lamotrigine, lansoprazole, lapatinib, laropiprant, lenalidomide, lercanidipine, leuprorelin acetate, levodopa, levonorgestrel, liraglutide, lisinopril, losartan, lutropin alpha, Lyme disease, macrogol, magnesium, mania, maraviroc, mecasermin, melatonergic, melatonin, meloxicam, memantine, mesalazine, metastatic colorectal carcinoma, metformin, methadone, methylnaltrexone bromide, methylphenidate hydrochloride, mexiletine hydrochloride, micafungin, migraine, mirtazapine, mixed dyslipidaemia, moxifloxacin, multiple myeloma, multiple sclerosis, muscular disorders, myelodysplastic syndromes, myocardial infarction, naloxone, naratriptan, nasal congestion, nausea, nebivolol, nephropathy, neural tube defects, neutropenia, NICE guidelines, nicotine, nicotinic acid, nilotinib, NSCLC, nutrition, OCD, ocular hypertension, olanzapine, olmesartan, omeprazole, ondensetron, open angle glaucoma, opioid addiction, opioid analgesic, opioid-induced constipation, oseltamivir, osteoarthritis, osteonecrosis of the jaw, osteoporosis, otitis, ovarian cancer, overactive bladder syndrome, oxycodone, paclitaxel, pain, pancreatic cancer, pancreatic exocrine insufficiency, pancreatin, panic disorder, panitumumab, pantoprazole, paracetamol, Parkinson’s, partial-onset seizures, patch, pemetrexed, peptic ulcer, perindopril, peripheral arterial disease, peripheral neuropathic pain, pertussis, piperacillin, Pityriasis versicolor, poliomyelitis, post transplantation hyperlipidaemia, post-operative pain, post-traumatic stress disorder, PPIs, pramipexole, pravastatin, pregnancy, pricing policy, primary hypercholesterolaemia, probiotics, prostate cancer, protamine sulphate, Pseudomonas aeruginosa, psoriasis, psychotic disorders, pulmonary arterial hypertension, pulmonary embolism, quetiapine, raltegravir, ramipril, ranolazine, rasagiline, recombinant IGF-1, reflux oesophagitis, renal disease, renin inhibitor, Restless Legs Syndrome, rheumatoid arthritis, ribavirin, ringworm, risedronate sodium, risperidone, rivaroxaban, rivastigmine, romiplostim, ropinirole, rosacea, RTI, S. aureus, salbutamol, sarcoma, saxagliptin, schizophrenia, SCLC, sertraline, sevelamer carbonate, severe pain, simvastatin, sitagliptin, smoking cessation, sodium alginate, solide organ transplantation, sorafenib, sore throat, spasticity, spinal cord injury, sport, sprain, statins, stroke, strontium ranelate, suicide, systemic embolisation, telmisartan, temsirolimus, terbinafine, testosterone, tetanus, thalidomide, thrombocytopenic purpura, thrush, tibolone, timolol, tinea, tiotropium, tipranavir, tizanidine, tobramycin, tocilizumab, topotecan, trabectedin, tramadol, Trichophyton, trimethoprim, trospium chloride, ustekinumab, UTI, vaccine, valaciclovir, valproate, valsartan, varenicline, venlafaxine, venous thromboembolism, venous thrombosis, vildagliptin, vinorelbine, vitamin D, vomiting, WADA, warfarin, wound, zanamivir, zoledronic acid, Zollinger-Ellison syndrome

MIMS Ireland: July 2008

Ca, vit D and proteins

Calcium, vitamin D, proteins | 01 July 2008 | Clinical Specials

THE EVIDENCE BEHIND THE KEY ROLE OF CALCIUM, VITAMIN D AND PROTEINS Experts at a recent nutritional symposium have concluded that fortified food or supplements including calcium, folic acid and vitamins, can play an important role to improve the nutrient... Read more

Champix (varenicline)

01 July 2008 | Irish Medicines Board

Champix (varenicline) is a medicinal product authorised for use throughout the European Union through the European licensing process for the treatment of smoking cessation in adults. It is a non-nicotine aid which can help relieve the cravings and withdrawal symptoms... Read more

Vitamin D Facts and Figures

01 July 2008 | Clinical Specials

Beyond bones For the last 80 years we have focused on the link between vitamin D and calcium economy – vitamin D is necessary for calcium absorption and its deficiency leads to rickets. But this is just the visible part... Read more

Folate and neural tube defects

01 July 2008 | Clinical Specials

Current Concerns • Ireland still has one of the highest rates of incidence of neural tube defects (NTDs) in Europe (0.8 - 1.5 cases per 1,000 births)... Read more

Aripez

01 July 2008 | New Products

Company: TEVA Pharmaceuticals Ireland. Legal category: Prescription. GMS. Sport Permitted. Active ingredient: Donepezil (hydrochloride) 5mg, 10mg (equivalent to 4.56mg, 9.12mg donepezil). Description: Film-coated oval shaped tablets, marked with 93 on one side. 5mg, white marked 7320 on the other side;... Read more

BabyVitD3

01 July 2008 | New Products

Company: Shield Health Ltd. Legal category: OTC. GMS pending. Active ingredient: Cholecalciferol 100IU/drop. Description: Solution in child safety dropper bottle. Presentation: 10ml (340 drops), €6.63. Indications: Vitamin D supplement for infants.... Read more

Cantaxel

01 July 2008 | New Products

Company: Clonmel Healthcare Ltd. Legal category: Prescription. Sport permitted. Active ingredient: Paclitaxel 6mg/ml. Description: Clear colourless or slightly yellow viscous solution for infusion in vial. Presentation: 5ml, €147.25;16.7ml, €441.75; 25ml, €661.68; 50ml, €1323.35. Indications: Ovarian cancer: First-line treatment of advanced... Read more

Pendrex

01 July 2008 | New Products

Company: Rowex Ltd. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Perindopril tert-butylamine 2mg (equivalent to 1.669mg perindopril), 4mg (equivalent to 3.338mg perindopril). Description: White, round, biconvex tablet debossed with 2 (2mg) or 4 (4mg) on one side. Presentation: 2mg-30,... Read more

Seretral

01 July 2008 | New Products

Company: TEVA Pharmaceuticals Ireland. Legal category: Prescription. GMS. Sport Permitted. Active ingredient: Sertraline (HCl) 50mg, 100mg. Description: Light blue (50mg tablet) or yellow (100mg tablet) elliptical shaped, film-coated tablet, one side scored and marked 9 and 3 from each side... Read more

Vectibix

01 July 2008 | New Products

Company: Amgen Ltd. Legal category: Hospital. Sport permitted. Active ingredient: Panitumumab 20mg/ml. Description: Solution in vial. Presentation: 5ml, €488.70. Indications: Monotherapy for the treatment of EGFR expressing metastatic colorectal carcinoma with non-mutated (wild-type) KRAS after failure of fluoropyrimidine-, oxaliplatin-, and... Read more

Eligard

01 July 2008 | New Presentations

Company: Astellas Pharma Co. Ltd. Legal category: Prescription. HT. Sport prohibited in men. Active ingredient: Leuprorelin acetate 45mg. Description: Powder and solvent for solution for injection. Presentation: 45mg, €882.05. Indications: Hormone dependent advanced prostate cancer.... Read more

Motilium Fastmelts

01 July 2008 | New Presentations

Company: McNeil Healthcare Ireland Ltd. Legal category: OTC. Sport permitted. Active ingredient: Domperidone 10mg. Description: White or off-white circular orodispersible tablet. Presentation: 10, €3.99; 20, €7.00. Indications: For the relief of post-prandial symptoms of fullness, nausea, epigastric bloating and belching... Read more

Pentasa

01 July 2008 | New Presentations

Company: Ferring Ireland Ltd. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Mesalazine 2g. Description: Whitish to pale brown prolonged-release granules in sachet. Presentation: 60, €97.92. Indications: Mild to moderate ulcerative colitis.... Read more

Rebif

01 July 2008 | New Presentations

Company: Merck Serono. Legal category: Prescription. HT. Sport permitted. Active ingredient: Interferon beta-1a, 8.8mcg/0.2ml, 22mcg/0.5ml, 44mcg/0.5ml. Description: Clear to opalescent solution for injection in pre-filled syringes. Presentation: 8.8mcg-6 and 22mcg-6 (initiation pack); 22mcg-12; 44mcg-12; Prices available on request. Indications: Treatment... Read more

EBIXA – New Once-Daily dosing

01 July 2008 | New this Month

Lundbeck (Ireland) Ltd wish to announce that they received approval from the European Medicines Agency (EMEA) for a new Once-Daily dosing of their NMDA receptor antagonist Ebixa (memantine) for the treatment of moderate to severe Alzheimer’s disease. The approval is... Read more

Change of product name from Laxoberal Liquid to Dulcolax Liquid

01 July 2008 | New this Month

Boehringer Ingelheim wishes to inform you that Laxoberal oral solution is changing name from Laxoberal Liquid 5mg/ml to Dulcolax Liquid in Ireland. There is no change in product composition.... Read more

Change of formulation for Rebif

01 July 2008 | New this Month

Merck Serono wishes to announce that Rebif New Formulation (interferon beta-1a) is now available in Ireland. In a recent 96 week Phase IIIb study, 260 patients with relapsing remitting multiple sclerosis treated with the new formulation experienced a near three-fold... Read more

Debossing of Zoton FasTab

01 July 2008 | New this Month

Wyeth Pharmaceuticals Ltd. would like to inform you of the debossing of Zoton FasTab 15mg oro-dispersible tablets and Zoton FasTab 30mg orodispersible tablets. Zoton FasTab 15mg oro-dispersible tablets will be debossed with 15 on one side; Zoton FasTab 30mg oro-dispersible... Read more

Discontinuations in the Depixol and Clopixol ranges from the Irish market

01 July 2008 | Discontinued Products

Lundbeck (Ireland) Ltd has announced the discontinuation from the Irish market of some presentations in the Depixol/Clopixol product ranges. The presentations to be discontinued are: Depixol Conc. 100mg/ml, solution for injection (10 × 0.5ml ampoules), Depixol 40mg/2ml, solution for injection... Read more

Discontinuation of Metocyl 10mg Tablets

01 July 2008 | Discontinued Products

Rowa Pharmaceuticals Ltd would like to announce their intention to discontinue Metocyl 10mg Tablets 20’s & 100’s once existing stock is depleted. The expiry date of the last batch is: 10-2010.... Read more

Discontinuation of Prozac Weekly Caps

01 July 2008 | Discontinued Products

Eli Lilly wish to announce the withdrawal from the market of Prozac Weekly Caps once existing stocks have been depleted. Prozac 20mg Caps, and Prozac liquid will continue to remain available.... Read more

Discontinuation of Rocephin 2g from the Irish market

01 July 2008 | Discontinued Products

Roche Products (Ireland) Ltd wish to inform you of the discontinuation of one of its products, Rocephin 2g powder for solution for injection or infusion. Due to low demand for the Rocephin 2g presentation, marketing of the product will cease... Read more

Discontinuation of Zineryt 90ml Pack

01 July 2008 | Discontinued Products

Astellas Pharma Co. Ltd would like to inform you that Zineryt 90ml pack size is being discontinued. This change will come into effect once the current stocks of Zineryt 90ml have been depleted. Zineryt 30ml pack remains on the market.... Read more